Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents

Brian Boylan, Michael Claude Berndt, Mark L Kahn, Peter J Newman

Research output: Contribution to journalArticleResearchpeer-review

55 Citations (Scopus)
Original languageEnglish
Pages (from-to)908 - 914
Number of pages7
JournalBlood
Volume108
Issue number3
DOIs
Publication statusPublished - 2006

Cite this

@article{3e554b06031d4d3280c4402593c07297,
title = "Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents",
author = "Brian Boylan and Berndt, {Michael Claude} and Kahn, {Mark L} and Newman, {Peter J}",
year = "2006",
doi = "10.1182/blood-2005-07-2937",
language = "English",
volume = "108",
pages = "908 -- 914",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "3",

}

Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents. / Boylan, Brian; Berndt, Michael Claude; Kahn, Mark L; Newman, Peter J.

In: Blood, Vol. 108, No. 3, 2006, p. 908 - 914.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents

AU - Boylan, Brian

AU - Berndt, Michael Claude

AU - Kahn, Mark L

AU - Newman, Peter J

PY - 2006

Y1 - 2006

U2 - 10.1182/blood-2005-07-2937

DO - 10.1182/blood-2005-07-2937

M3 - Article

VL - 108

SP - 908

EP - 914

JO - Blood

JF - Blood

SN - 0006-4971

IS - 3

ER -